Hon’ble President of India Smt. Droupadi Murmu confers the coveted Padma Shri Award on Dr P. Vijay Anand Reddy

IMT News Desk
IMT News Desk
· 1 min read
Hon’ble President Droupadi Murmu confers Padma Shri on Dr P. Vijay Anand Reddy, honouring his pioneering oncology work & service through CURE Foundation.

Hon’ble President of India Smt. Droupadi Murmu conferred the coveted Padma Shri Award on Dr P. Vijay Anand Reddy, Founder of CURE Foundation and Director, Apollo Cancer Centres, Hyderabad.

Expressing his gratitude, Dr P. Vijay Anand Reddy said, I accept this honour with profound humility and gratitude and extend my heartfelt thanks to the Hon’ble President of India and the Government of India for recognising my work with this prestigious honour. This recognition is not merely a reflection of my individual journey but a tribute to the tireless dedication of the entire oncology fraternity, my colleagues, mentors, patients, and family, who have stood by me at every step.

This award further strengthens my resolve to serve society with greater commitment, compassion, and purpose. I dedicate this recognition to my patients, especially the children and families whose courage and resilience continue to inspire me every single day, Dr Reddy adds.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk